JAK2V617F Mutation Screening as Part of the Hypercoagulable Work-up in the Absence of Splanchnic Venous Thrombosis or Overt Myeloproliferative Neoplasm: Assessment of Value in a Series of 664 Consecutive Patients
- 1 April 2008
- journal article
- research article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 83 (4), 457-459
- https://doi.org/10.4065/83.4.457
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithmsLeukemia, 2007
- JAK2V617F in idiopathic venous thromboembolism occurring in the absence of inherited or acquired thrombophiliaBritish Journal of Haematology, 2007
- JAK2V617F is infrequently associated with arterial stroke in the absence of overt myeloproliferative disorderJournal of Thrombosis and Haemostasis, 2007
- JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorderLeukemia, 2007
- JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosisJournal of Thrombosis and Haemostasis, 2007
- Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settingsJournal of Medical Genetics, 2007
- Role of theJAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosisHepatology, 2006
- Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosisBlood, 2006
- Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd–Chiari SyndromeGastroenterology, 2006
- Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemiaBritish Journal of Haematology, 2005